Additional file 2: of Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth

Figure S1. Representative gating strategy for the identification of neoantigen specific immune responses. Figure S2. Comparison of CEA specific immune responses induced by the M1 vaccine vector vs. the full length CEA protein delivered by DNA-EP. Figure S3. Comparison in peripheral blood by IFN-Îł ICS analysis for the Reps1 neoantigen and cognate WT peptide. Figure S4. M2 specific memory T cells. Figure S5. M3 specific T cells. Figure S6. Immuno modulators prevent MC38 tumor growth. (PPTX 1226 kb)